Phagenesis

Manchester, United Kingdom · Founded 2007 · Privately Held (backing)

Developer of a medical device designed to provide treatment of acute dysphagia. Phagenesis is based in Manchester, United Kingdom and was founded in 2007. Its last reported valuation was $51.3 million in Aug 2025. It has raised $90 million.

Last reported valuation
$51.3M
Oct 2026
Priced at
—
Total raised
$90.0M
Last round
—

Who backs Phagenesis?

11 investors
InvestorType
MedTech InnovatorOther
British Business BankOther
Wellcome TrustOther
Northern GritstoneVenture capital
Nestlé Health ScienceOther
Anglo Scientific—
Aphelion—
Innvotec—
Nestle UK—
Sectoral Asset Management—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Phagenesis investors

11 investors are on record for Phagenesis, including MedTech Innovator, British Business Bank, Wellcome Trust and Northern Gritstone.

Free account
More of Phagenesis with a free account
  • ·The complete investor list: 11 names
  • ·Watch Phagenesis: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Phagenesis. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View